Ultrasonic Tissue Ablation System Market Size to Hit USD 2,114.90 Million by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Ultrasonic Tissue Ablation System Market, By Technology

7.1. Ultrasonic Tissue Ablation System Market, by January

7.1.1. High-Intensity Focused Ultrasound (HIFU) Systems

7.1.1.1. Market Revenue and Forecast

7.1.2. MR-Guided Focused Ultrasound Systems

7.1.2.1. Market Revenue and Forecast

7.1.3. Ultrasound-Guided Focused Ultrasound Systems

7.1.3.1. Market Revenue and Forecast

7.1.4. Histotripsy Systems

7.1.4.1. Market Revenue and Forecast

7.1.5. Transurethral Ultrasound Ablation Systems

7.1.5.1. Market Revenue and Forecast

7.1.6. Other Ultrasonic Ablation Platforms

7.1.61. Market Revenue and Forecast

Chapter 8. Global Ultrasonic Tissue Ablation System Market, By Modality

8.1. Ultrasonic Tissue Ablation System Market, by Modality

8.1.1. Non-Invasive Extracorporeal Systems

8.1.1.1. Market Revenue and Forecast

8.1.2. Minimally Invasive Transurethral Systems

8.1.2.1. Market Revenue and Forecast

8.1.3. Laparoscopic / Intraoperative Ultrasonic Ablation Systems

8.1.3.1. Market Revenue and Forecast

8.1.4. Robot-Assisted Integrated Ablation Systems

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Ultrasonic Tissue Ablation System Market, By Application

9.1. Ultrasonic Tissue Ablation System Market, by Application

9.1.1. Oncology

9.1.1.1. Market Revenue and Forecast

9.1.2. Urology

9.1.2.1. Market Revenue and Forecast

9.1.3. Neurology

9.1.3.1. Market Revenue and Forecast

9.1.4. Gynecology

9.1.4.1. Market Revenue and Forecast

9.1.5. Breast and Endocrine Lesions

9.1.5.1. Market Revenue and Forecast

9.1.6. Cardiovascular / Vascular

9.1.6.1. Market Revenue and Forecast

9.1.7. Pain Palliation

9.1.7.1. Market Revenue and Forecast

Chapter 10. Global Ultrasonic Tissue Ablation System Market, By Indication

10.1. Ultrasonic Tissue Ablation System Market, by Indication

10.1.1. Liver Tumors

10.1.1.1. Market Revenue and Forecast

10.1.2. Prostate Tissue Ablation

10.1.2.1. Market Revenue and Forecast

10.1.3. Uterine Fibroids and Adenomyosis

10.1.3.1. Market Revenue and Forecast

10.1.4. Essential Tremor and Parkinsonian Tremor

10.1.4.1. Market Revenue and Forecast

10.1.5. Thyroid Nodules

10.1.5.1. Market Revenue and Forecast

10.1.6. Breast Fibroadenoma and Benign Breast Lesions

10.1.6.1. Market Revenue and Forecast

10.1.7. Pancreatic, Kidney, and Other Solid Tumors

10.1.7.1. Market Revenue and Forecast

10.1.8. Varicose Veins and Other Niche Soft Tissue Lesions

10.1.8.1. Market Revenue and Forecast

Chapter 11. Global Ultrasonic Tissue Ablation System Market, By End User

11.1. Ultrasonic Tissue Ablation System Market, by End User

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast

11.1.2. Specialty Clinics

11.1.2.1. Market Revenue and Forecast

11.1.3. Ambulatory Surgical Centers

11.1.3.1. Market Revenue and Forecast

11.1.4. Cancer Centers

11.1.4.1. Market Revenue and Forecast

11.1.5. Academic and Research Institutes

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Ultrasonic Tissue Ablation System Market, By System Configuration

12.1. Ultrasonic Tissue Ablation System Market, by System Configuration

12.1.1. Cart-Based Systems

12.1.1.1. Market Revenue and Forecast

12.1.2. Console / Room-Based Integrated Systems

12.1.2.1. Market Revenue and Forecast

12.1.3. Robotic Image-Guided Platforms

12.1.3.1. Market Revenue and Forecast

Chapter 13. Global Ultrasonic Tissue Ablation System Market, By Component

13.1. Ultrasonic Tissue Ablation System Market, by Component

13.1.1. Capital Equipment

13.1.1.1. Market Revenue and Forecast

13.1.2. Handpieces and Transducers

13.1.2.1. Market Revenue and Forecast

13.1.3. Planning and Imaging Software

13.1.3.1. Market Revenue and Forecast

13.1.4. Service and Maintenance

13.1.4.1. Market Revenue and Forecast

Chapter 14. Global Ultrasonic Tissue Ablation System Market, By Procedure Setting

14.1. Ultrasonic Tissue Ablation System Market, by Procedure Setting

14.1.1. Inpatient Setting

14.1.1.1. Market Revenue and Forecast

14.1.2. Outpatient Hospital Setting

14.1.2.1. Market Revenue and Forecast

14.1.3. Office-Based / Day Care Setting

14.1.3.1. Market Revenue and Forecast

14.1.4. Mobile / Shared Access Setting

14.1.4.1. Market Revenue and Forecast

Chapter 15. Global Ultrasonic Tissue Ablation System Market, Regional Estimates and Trend Forecast

15.1. North America

15.1.1. Market Revenue and Forecast, by January

15.1.2. Market Revenue and Forecast, by Modality

15.1.3. Market Revenue and Forecast, by Application

15.1.4. Market Revenue and Forecast, by Indication

15.1.5. Market Revenue and Forecast, by End User

15.1.6. Market Revenue and Forecast, by System Configuration

15.1.7. Market Revenue and Forecast, by Component

15.1.8. Market Revenue and Forecast, by Procedure Setting

15.1.9. U.S.

15.1.9.1. Market Revenue and Forecast, by January

15.1.9.2. Market Revenue and Forecast, by Modality

15.1.9.3. Market Revenue and Forecast, by Application

15.1.9.4. Market Revenue and Forecast, by Indication

15.1.9.5. Market Revenue and Forecast, by End User

15.1.9.6. Market Revenue and Forecast, by System Configuration

15.1.9.7. Market Revenue and Forecast, by Component

15.1.9.8. Market Revenue and Forecast, by Procedure Setting

15.1.10. Rest of North America

15.1.10.1. Market Revenue and Forecast, by January

15.1.10.2. Market Revenue and Forecast, by Modality

15.1.10.3. Market Revenue and Forecast, by Application

15.1.10.4. Market Revenue and Forecast, by Indication

15.1.10.5. Market Revenue and Forecast, by End User

15.1.10.6. Market Revenue and Forecast, by System Configuration

15.1.10.7. Market Revenue and Forecast, by Component

15.1.10.8. Market Revenue and Forecast, by Procedure Setting

15.2. Europe

15.2.1. Market Revenue and Forecast, by January

15.2.2. Market Revenue and Forecast, by Modality

15.2.3. Market Revenue and Forecast, by Application

15.2.4. Market Revenue and Forecast, by Indication

15.2.5. Market Revenue and Forecast, by End User

15.2.6. Market Revenue and Forecast, by System Configuration

15.2.7. Market Revenue and Forecast, by Component

15.2.8. Market Revenue and Forecast, by Procedure Setting

15.2.9. UK

15.2.9.1. Market Revenue and Forecast, by January

15.2.9.2. Market Revenue and Forecast, by Modality

15.2.9.3. Market Revenue and Forecast, by Application

15.2.9.4. Market Revenue and Forecast, by Indication

15.2.9.5. Market Revenue and Forecast, by End User

15.2.9.6. Market Revenue and Forecast, by System Configuration

15.2.9.7. Market Revenue and Forecast, by Component

15.2.9.8. Market Revenue and Forecast, by Procedure Setting

15.2.10. Germany

15.2.10.1. Market Revenue and Forecast, by January

15.2.10.2. Market Revenue and Forecast, by Modality

15.2.10.3. Market Revenue and Forecast, by Application

15.2.10.4. Market Revenue and Forecast, by Indication

15.2.10.5. Market Revenue and Forecast, by End User

15.2.10.6. Market Revenue and Forecast, by System Configuration

15.2.10.7. Market Revenue and Forecast, by Component

15.2.10.8. Market Revenue and Forecast, by Procedure Setting

15.2.11. France

15.2.11.1. Market Revenue and Forecast, by January

15.2.11.2. Market Revenue and Forecast, by Modality

15.2.11.3. Market Revenue and Forecast, by Application

15.2.11.4. Market Revenue and Forecast, by Indication

15.2.11.5. Market Revenue and Forecast, by End User

15.2.11.6. Market Revenue and Forecast, by System Configuration

15.2.11.7. Market Revenue and Forecast, by Procedure Setting

15.2.11.8. Market Revenue and Forecast, by Component

15.2.12. Rest of Europe

15.2.12.1. Market Revenue and Forecast, by January

15.2.12.2. Market Revenue and Forecast, by Modality

15.2.12.3. Market Revenue and Forecast, by Application

15.2.12.4. Market Revenue and Forecast, by Indication

15.2.12.5. Market Revenue and Forecast, by End User

15.2.12.6. Market Revenue and Forecast, by System Configuration

15.2.12.7. Market Revenue and Forecast, by Component

15.2.12.8. Market Revenue and Forecast, by Procedure Setting

15.3. APAC

15.3.1. Market Revenue and Forecast, by January

15.3.2. Market Revenue and Forecast, by Modality

15.3.3. Market Revenue and Forecast, by Application

15.3.4. Market Revenue and Forecast, by Indication

15.3.5. Market Revenue and Forecast, by End User

15.3.6. Market Revenue and Forecast, by System Configuration

15.3.7. Market Revenue and Forecast, by Component

15.3.8. Market Revenue and Forecast, by Procedure Setting

15.3.9. India

15.3.9.1. Market Revenue and Forecast, by January

15.3.9.2. Market Revenue and Forecast, by Modality

15.3.9.3. Market Revenue and Forecast, by Application

15.3.9.4. Market Revenue and Forecast, by Indication

15.3.9.5. Market Revenue and Forecast, by End User

15.3.9.6. Market Revenue and Forecast, by System Configuration

15.3.9.7. Market Revenue and Forecast, by Component

15.3.9.8. Market Revenue and Forecast, by Procedure Setting

15.3.10. China

15.3.10.1. Market Revenue and Forecast, by January

15.3.10.2. Market Revenue and Forecast, by Modality

15.3.10.3. Market Revenue and Forecast, by Application

15.3.10.4. Market Revenue and Forecast, by Indication

15.3.10.5. Market Revenue and Forecast, by End User

15.3.10.6. Market Revenue and Forecast, by System Configuration

15.3.10.7. Market Revenue and Forecast, by Component

15.3.10.8. Market Revenue and Forecast, by Procedure Setting

15.3.11. Japan

15.3.11.1. Market Revenue and Forecast, by January

15.3.11.2. Market Revenue and Forecast, by Modality

15.3.11.3. Market Revenue and Forecast, by Application

15.3.11.4. Market Revenue and Forecast, by Indication

15.3.11.5. Market Revenue and Forecast, by End User

15.3.11.6. Market Revenue and Forecast, by System Configuration

15.3.11.7. Market Revenue and Forecast, by Component

15.3.11.8. Market Revenue and Forecast, by Procedure Setting

15.3.12. Rest of APAC

15.3.12.1. Market Revenue and Forecast, by January

15.3.12.2. Market Revenue and Forecast, by Modality

15.3.12.3. Market Revenue and Forecast, by Application

15.3.12.4. Market Revenue and Forecast, by Indication

15.3.12.5. Market Revenue and Forecast, by End User

15.3.12.6. Market Revenue and Forecast, by System Configuration

15.3.12.7. Market Revenue and Forecast, by Component

15.3.12.8. Market Revenue and Forecast, by Procedure Setting

15.4. MEA

15.4.1. Market Revenue and Forecast, by January

15.4.2. Market Revenue and Forecast, by Modality

15.4.3. Market Revenue and Forecast, by Application

15.4.4. Market Revenue and Forecast, by Indication

15.4.5. Market Revenue and Forecast, by End User

15.4.6. Market Revenue and Forecast, by System Configuration

15.4.7. Market Revenue and Forecast, by Component

15.4.8. Market Revenue and Forecast, by Procedure Setting

15.4.9. GCC

15.4.9.1. Market Revenue and Forecast, by January

15.4.9.2. Market Revenue and Forecast, by Modality

15.4.9.3. Market Revenue and Forecast, by Application

15.4.9.4. Market Revenue and Forecast, by Indication

15.4.9.5. Market Revenue and Forecast, by End User

15.4.9.6. Market Revenue and Forecast, by System Configuration

15.4.9.7. Market Revenue and Forecast, by Component

15.4.9.8. Market Revenue and Forecast, by Procedure Setting

15.4.10. North Africa

15.4.10.1. Market Revenue and Forecast, by January

15.4.10.2. Market Revenue and Forecast, by Modality

15.4.10.3. Market Revenue and Forecast, by Application

15.4.10.4. Market Revenue and Forecast, by Indication

15.4.10.5. Market Revenue and Forecast, by End User

15.4.10.6. Market Revenue and Forecast, by System Configuration

15.4.10.7. Market Revenue and Forecast, by Component

15.4.10.8. Market Revenue and Forecast, by Procedure Setting

15.4.11. South Africa

15.4.11.1. Market Revenue and Forecast, by January

15.4.11.2. Market Revenue and Forecast, by Modality

15.4.11.3. Market Revenue and Forecast, by Application

15.4.11.4. Market Revenue and Forecast, by Indication

15.4.11.5. Market Revenue and Forecast, by End User

15.4.11.6. Market Revenue and Forecast, by System Configuration

15.4.11.7. Market Revenue and Forecast, by Component

15.4.11.8. Market Revenue and Forecast, by Procedure Setting

15.4.12. Rest of MEA

15.4.12.1. Market Revenue and Forecast, by January

15.4.12.2. Market Revenue and Forecast, by Modality

15.4.12.3. Market Revenue and Forecast, by Application

15.4.12.4. Market Revenue and Forecast, by Indication

15.4.12.5. Market Revenue and Forecast, by End User

15.4.12.6. Market Revenue and Forecast, by System Configuration

15.4.12.7. Market Revenue and Forecast, by Component

15.4.12.8. Market Revenue and Forecast, by Procedure Setting

15.5. Latin America

15.5.1. Market Revenue and Forecast, by January

15.5.2. Market Revenue and Forecast, by Modality

15.5.3. Market Revenue and Forecast, by Application

15.5.4. Market Revenue and Forecast, by Indication

15.5.5. Market Revenue and Forecast, by End User

15.5.6. Market Revenue and Forecast, by System Configuration

15.5.7. Market Revenue and Forecast, by Component

15.5.8. Market Revenue and Forecast, by Procedure Setting

15.5.9. Brazil

15.5.9.1. Market Revenue and Forecast, by January

15.5.9.2. Market Revenue and Forecast, by Modality

15.5.9.3. Market Revenue and Forecast, by Application

15.5.9.4. Market Revenue and Forecast, by Indication

15.5.9.5. Market Revenue and Forecast, by End User

15.5.9.6. Market Revenue and Forecast, by System Configuration

15.5.9.7. Market Revenue and Forecast, by Component

15.5.9.8. Market Revenue and Forecast, by Procedure Setting

15.5.10. Rest of LATAM

15.5.10.1. Market Revenue and Forecast, by January

15.5.10.2. Market Revenue and Forecast, by Modality

15.5.10.3. Market Revenue and Forecast, by Application

15.5.10.4. Market Revenue and Forecast, by Indication

15.5.10.5. Market Revenue and Forecast, by End User

15.5.10.6. Market Revenue and Forecast, by System Configuration

15.5.10.7. Market Revenue and Forecast, by Component

15.5.10.8. Market Revenue and Forecast, by Procedure Setting

Chapter 16. Company Profiles

16.1. Insightec

16.1.1. Company Overview

16.1.2. Product Offerings

16.1.3. Financial Performance

16.1.4. Recent Initiatives

16.2. HistoSonics

16.2.1. Company Overview

16.2.2. Product Offerings

16.2.3. Financial Performance

16.2.4. Recent Initiatives

16.3. Profound Medical

16.3.1. Company Overview

16.3.2. Product Offerings

16.3.3. Financial Performance

16.3.4. Recent Initiatives

16.4. EDAP TMS

16.4.1. Company Overview

16.4.2. Product Offerings

16.4.3. Financial Performance

16.4.4. Recent Initiatives

16.5. SonaCare Medical

16.5.1. Company Overview

16.5.2. Product Offerings

16.5.3. Financial Performance

16.5.4. Recent Initiatives

16.6. Theraclion

16.6.1. Company Overview

16.6.2. Product Offerings

16.6.3. Financial Performance

16.6.4. Recent Initiatives

16.7. Chongqing Haifu Medical Technology

16.7.1. Company Overview

16.7.2. Product Offerings

16.7.3. Financial Performance

16.7.4. Recent Initiatives

16.8. Alpinion Medical Systems

16.8.1. Company Overview

16.8.2. Product Offerings

16.8.3. Financial Performance

16.8.4. Recent Initiatives

16.9. Philips

16.9.1. Company Overview

16.9.2. Product Offerings

16.9.3. Financial Performance

16.9.4. Recent Initiatives

16.10. GE HealthCare

16.10.1. Company Overview

16.10.2. Product Offerings

16.10.3. Financial Performance

16.10.4. Recent Initiatives

Chapter 17. Research Methodology

16.7. Primary Research

16.7. Secondary Research

16.7. Assumptions

Chapter 18. Appendix

18.1. About Us

18.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The ultrasonic tissue ablation system market size is expected to increase from USD 594.02 million in 2025 to USD 2,114.90 million by 2035.

Answer : The ultrasonic tissue ablation system market is expected to grow at a compound annual growth rate (CAGR) of around 13.54% from 2026 to 2035.

Answer : The major players in the ultrasonic tissue ablation system market include Insightec, HistoSonics, Profound Medical, EDAP TMS, SonaCare Medical, Theraclion, Chongqing Haifu Medical Technology, Alpinion Medical Systems, Philips, GE HealthCare, Siemens Healthineers, JC Medical, Mianyang Sonic Electronic, FUSMobile and Image Guided Therapy.

Answer : The driving factors of the ultrasonic tissue ablation system market are the growing demand for minimally invasive and safer tissue ablation therapy.

Answer : North America region will lead the global ultrasonic tissue ablation system market during the forecast period 2026 to 2035.